Oral intake of curcumin markedly activated CYP 3A4: in vivo and ex-vivo studies.
about
Modulation of Metabolic Detoxification Pathways Using Foods and Food-Derived Components: A Scientific Review with Clinical ApplicationCurcumin as therapeutics for the treatment of head and neck squamous cell carcinoma by activating SIRT1Modulation of Hepatic Cytochrome P450 Enzymes by Curcumin and its Pharmacokinetic Consequences in Sprague-dawley RatsCurcumin Prevents Aflatoxin B₁ Hepatoxicity by Inhibition of Cytochrome P450 Isozymes in Chick Liver.Influence of curcumin on the pharmacodynamics and pharmacokinetics of gliclazide in animal modelsAloe activated P-glycoprotein and CYP 3A: a study on the serum kinetics of aloe and its interaction with cyclosporine in rats.
P2860
Oral intake of curcumin markedly activated CYP 3A4: in vivo and ex-vivo studies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 October 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Oral intake of curcumin markedly activated CYP 3A4: in vivo and ex-vivo studies.
@en
Oral intake of curcumin markedly activated CYP 3A4: in vivo and ex-vivo studies.
@nl
type
label
Oral intake of curcumin markedly activated CYP 3A4: in vivo and ex-vivo studies.
@en
Oral intake of curcumin markedly activated CYP 3A4: in vivo and ex-vivo studies.
@nl
prefLabel
Oral intake of curcumin markedly activated CYP 3A4: in vivo and ex-vivo studies.
@en
Oral intake of curcumin markedly activated CYP 3A4: in vivo and ex-vivo studies.
@nl
P2093
P2860
P356
P1433
P1476
Oral intake of curcumin markedly activated CYP 3A4: in vivo and ex-vivo studies.
@en
P2093
Ching-Ya Huang
Pei-Dawn Lee Chao
Shih-Ying Yang
Yow-Wen Hsieh
Yu-Hsuan Peng
P2860
P2888
P356
10.1038/SREP06587
P407
P577
2014-10-10T00:00:00Z